Literature DB >> 30632458

The Role and Mechanism of miRNA-1224 in the Polygonatum sibiricum Polysaccharide Regulation of Bone Marrow-Derived Macrophages to Osteoclast Differentiation.

Bo Li1, Pingping Wu1, Wenwen Fu1, Yin Xiong1, Lei Zhang1, Yunbing Gao2, GuiYing Deng2, Shaohui Zong2,3, Gaofeng Zeng1.   

Abstract

MicroRNAs (miRNAs) are endogenous noncoding small molecule RNAs that regulate cell proliferation, differentiation, fat metabolism, and hormone secretion. Studies have shown that miRNAs regulate the processes related to osteoporosis, including the differentiation of osteoblasts, osteoclasts, and chondrocytes, and are one of the important regulatory factors of some bone metabolic diseases. In our previous study, it has been revealed that natural compound Polygonatum sibiricum polysaccharide (PSP) can promote osteoblast formation and block osteoclastogenesis through Wnt/β-catenin signaling pathway. This study was designed to investigate whether PSP can inhibit expression of osteoclast-related genes by Hippo signaling pathway, which was prevented by effectively blocking the expression of miR-1224. This study showed that there were 27 differentially expressed miRNAs when PSP inhibits osteoclastogenesis, the most notable of which was miR-1224. Furthermore, the study showed that PSP increased the level of Limd1, which was the target gene of miR-1224. In conclusion, these findings demonstrate that PSP suppressed osteoclastogenesis in vitro through the Hippo signaling pathway based on miR-1224. This study may aid in the development of a therapeutic approach utilizing PSP for the enhancement of bone health and prevention of osteoporosis.

Entities:  

Keywords:  Hippo signaling pathway; Polygonatum sibiricum polysaccharide; miR-1224

Mesh:

Substances:

Year:  2019        PMID: 30632458     DOI: 10.1089/rej.2018.2126

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  7 in total

1.  ATF1/miR-214-5p/ITGA7 axis promotes osteoclastogenesis to alter OVX-induced bone absorption.

Authors:  Lu-Lin Liu; Yao-Sheng Xiao; Wei-Min Huang; Sheng Liu; Li-Xing Huang; Jing-Hua Zhong; Peng Jia; Wu-Yang Liu
Journal:  Mol Med       Date:  2022-05-14       Impact factor: 6.376

Review 2.  Antiosteoporosis Studies of 20 Medicine Food Homology Plants Containing Quercetin, Rutin, and Kaempferol: TCM Characteristics, In Vivo and In Vitro Activities, Potential Mechanisms, and Food Functions.

Authors:  Dayue Shen; Yating Feng; Xilan Zhang; Le Gong; Jing Liu; Yuanping Li; Hui Liao
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-31       Impact factor: 2.629

3.  MiR-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the Rap1 signaling target ADCY2.

Authors:  Liangcong Hu; Xudong Xie; Hang Xue; Tiantian Wang; Adriana C Panayi; Ze Lin; Yuan Xiong; Faqi Cao; Chengcheng Yan; Lang Chen; Peng Cheng; Kangkang Zha; Yun Sun; Guodong Liu; Chenyan Yu; Yiqiang Hu; Ranyang Tao; Wu Zhou; Bobin Mi; Guohui Liu
Journal:  Exp Mol Med       Date:  2022-07-13       Impact factor: 12.153

4.  Effects of steam on polysaccharides from Polygonatum cyrtonema based on saccharide mapping analysis and pharmacological activity assays.

Authors:  Zherui Chen; Baojie Zhu; Zhixin Chen; Wen Cao; Junqiao Wang; Shaoping Li; Jing Zhao
Journal:  Chin Med       Date:  2022-08-17       Impact factor: 4.546

5.  miR-1224 contributes to ischemic stroke-mediated natural killer cell dysfunction by targeting Sp1 signaling.

Authors:  Yan Feng; Yan Li; Ying Zhang; Bo-Hao Zhang; Hui Zhao; Xin Zhao; Fu-Dong Shi; Wei-Na Jin; Xiao-An Zhang
Journal:  J Neuroinflammation       Date:  2021-06-12       Impact factor: 8.322

6.  The Regulation of circRNA RNF13/miRNA-1224-5p Axis Promotes the Malignant Evolution in Acute Myeloid Leukemia.

Authors:  Rong Zhang; Yingchun Li; Hongtao Wang; Ke Zhu; Guojun Zhang
Journal:  Biomed Res Int       Date:  2020-10-06       Impact factor: 3.411

7.  miR-325-3p, a novel regulator of osteoclastogenesis in osteolysis of colorectal cancer through targeting S100A4.

Authors:  Li Chengling; Zhang Yulin; Xie Xiaoyu; Lu Xingchen; Zhang Sen; Wang Ziming; Chen Xianming
Journal:  Mol Med       Date:  2021-03-10       Impact factor: 6.354

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.